Novartis

Page 3 of 4

Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health

The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way

By
October 19, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health

Novartis CEO Joseph Jimenez Is Stepping Down

By
September 4, 2017
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
Health

Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?

By
August 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Commentary

Innovative Drugs Deserve Innovative Pricing

By David Agus, Dana Goldman and Bethany Cianciolo
August 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health

The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.

By
August 30, 2017
Close-up of young man placing blue and white tablet into mouth
Health

This Drug Is A Dual Threat Against Heart Disease and Cancer

By
August 28, 2017
Investing in Healthcare: Two Starkly Different Views
Health

Investing in Healthcare: Two Starkly Different Views

By
July 13, 2017
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
Health

FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers

By
July 12, 2017
The logo of the World Economic Forum is seen in the congress center of the annual meeting of the World Economic Forum (WEF) in Davos
Health

These World Leaders Have a Radical Idea for Health Care

By
April 27, 2017
Google and Novartis Won’t Be Testing Smart Contact Lenses This Year After All
Tech

Google and Novartis Won’t Be Testing Smart Contact Lenses This Year After All

By
November 18, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Health

Novartis Says MS Drug Cut Risk of Disability Advance in Study

By
September 17, 2016
The Davos World Economic Forum 2015
Health

Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share

By
August 31, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health

Novartis Asthma Pill Shows Promise in Small Trial

By
August 6, 2016
The Davos World Economic Forum 2015
Health

Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis

By
July 19, 2016
Close up of surgical tools and money
Health

Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition

By
July 15, 2016

Most Popular